Latest Investments News

Hartshead Resources NL’s takeover by ACAM GP Limited clears its final legal hurdle, triggering suspension of Hartshead shares and setting key dates for shareholder payouts.

Vita Life Sciences projects a slight increase in H1 2026 sales and stable pre-tax profits, supported by strong markets in Australia and Malaysia/Singapore but offset by regulatory headwinds in China.

Magellan Financial Group has won unconditional ACCC approval to merge with Barrenjoey Capital Partners, aiming to complete the deal by early July and rebrand as Barrenjoey Group pending shareholder approval.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

Woodside Energy has exercised its pre-emption right to acquire PetroChina's 10.67% interest in the Browse Joint Venture, increasing its stake to 41.27%. The deal includes a $225 million upfront payment and a $175 million contingent payment tied to a final investment decision by 2032.

MRG Metals has lodged a key Mining Right Conversion Application in South Africa for its Garies Rare Earth Project, setting the stage for scalable mining development supported by strong metallurgical results and a modular processing approach.

Reach Resources has locked in $6.05 million in fresh capital, including a $2 million option fee from Andel Resources, positioning the company to accelerate development at its Murchison South gold project.

Pursuit Minerals has expanded its Rio Grande Sur Lithium Project in Argentina by acquiring exclusive rights over 1,362 hectares adjacent to its Mito tenement, increasing the project area to over 10,595 hectares and enhancing its lithium brine resource potential.

Vault Minerals has submitted a fully certified Closure Plan Amendment for its Southern Tailings Management Facility, marking a regulatory milestone that supports a planned restart of underground development in Q1 FY27 and gold production in Q1 FY28 at Sugar Zone, Ontario.

Marlin Global’s portfolio lagged the broader market in May 2026, weighed down by semiconductor underexposure and near-term revenue challenges in key holdings, while AI-focused stocks powered a narrow rally.

Kingfish Limited's May update reveals a robust 5.5% portfolio return, driven by standout performances from Fisher & Paykel Healthcare and Infratil amid mixed sector headwinds.

Green Cross Health Limited reported a 28% rise in net profit to NZD 20.4 million for FY26, driven by gains in both pharmacy and medical divisions. The company announced a conditional sale of its Medical division to Tend Health for NZD 270 million, aiming to refocus on its core pharmacy business.